Annual Cash & Cash Equivalents
$467.29 M
+$316.83 M+210.56%
December 31, 2023
Summary
- As of February 7, 2025, GMED annual cash & cash equivalents is $467.29 million, with the most recent change of +$316.83 million (+210.56%) on December 31, 2023.
- During the last 3 years, GMED annual cash & cash equivalents has risen by +$227.90 million (+95.20%).
- GMED annual cash & cash equivalents is now at all-time high.
Performance
GMED Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$622.77 M
+$212.34 M+51.74%
September 30, 2024
Summary
- As of February 7, 2025, GMED quarterly cash and cash equivalents is $622.77 million, with the most recent change of +$212.34 million (+51.74%) on September 30, 2024.
- Over the past year, GMED quarterly cash and cash equivalents has increased by +$343.15 million (+122.72%).
- GMED quarterly cash and cash equivalents is now at all-time high.
Performance
GMED Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
GMED Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +210.6% | +122.7% |
| 3 y3 years | +95.2% | +122.7% |
| 5 y5 years | +234.6% | +122.7% |
GMED Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +210.6% | at high | +364.0% |
| 5 y | 5-year | at high | +210.6% | at high | +364.0% |
| alltime | all time | at high | +676.9% | at high | +1398.5% |
Globus Medical Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $622.77 M(+51.7%) |
| Jun 2024 | - | $410.42 M(+15.9%) |
| Mar 2024 | - | $354.06 M(-24.2%) |
| Dec 2023 | $467.29 M(+210.6%) | $467.29 M(+67.1%) |
| Sep 2023 | - | $279.62 M(-8.8%) |
| Jun 2023 | - | $306.45 M(+40.8%) |
| Mar 2023 | - | $217.69 M(+44.7%) |
| Dec 2022 | $150.47 M(-22.1%) | $150.47 M(+12.1%) |
| Sep 2022 | - | $134.22 M(-11.0%) |
| Jun 2022 | - | $150.77 M(-34.4%) |
| Mar 2022 | - | $229.79 M(+19.0%) |
| Dec 2021 | $193.07 M(-19.4%) | $193.07 M(-46.6%) |
| Sep 2021 | - | $361.88 M(+34.6%) |
| Jun 2021 | - | $268.78 M(+45.4%) |
| Mar 2021 | - | $184.85 M(-22.8%) |
| Dec 2020 | $239.40 M(+22.3%) | $239.40 M(-4.5%) |
| Sep 2020 | - | $250.61 M(+51.4%) |
| Jun 2020 | - | $165.55 M(-0.7%) |
| Mar 2020 | - | $166.74 M(-14.8%) |
| Dec 2019 | $195.72 M(+40.2%) | $195.72 M(+17.8%) |
| Sep 2019 | - | $166.09 M(+41.0%) |
| Jun 2019 | - | $117.79 M(-9.4%) |
| Mar 2019 | - | $129.98 M(-6.9%) |
| Dec 2018 | $139.65 M | $139.65 M(-3.9%) |
| Sep 2018 | - | $145.29 M(+21.1%) |
| Jun 2018 | - | $119.94 M(+0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $119.84 M(+0.9%) |
| Dec 2017 | $118.82 M(+77.5%) | $118.82 M(-23.3%) |
| Sep 2017 | - | $154.85 M(+3.5%) |
| Jun 2017 | - | $149.67 M(-18.0%) |
| Mar 2017 | - | $182.44 M(+172.5%) |
| Dec 2016 | $66.95 M(+11.3%) | $66.95 M(-25.8%) |
| Sep 2016 | - | $90.19 M(-5.4%) |
| Jun 2016 | - | $95.34 M(+17.3%) |
| Mar 2016 | - | $81.28 M(+35.1%) |
| Dec 2015 | $60.15 M(-26.9%) | $60.15 M(+19.1%) |
| Sep 2015 | - | $50.50 M(+21.5%) |
| Jun 2015 | - | $41.56 M(-44.6%) |
| Mar 2015 | - | $75.01 M(-8.8%) |
| Dec 2014 | $82.27 M(-8.6%) | $82.27 M(-51.5%) |
| Sep 2014 | - | $169.45 M(+24.1%) |
| Jun 2014 | - | $136.50 M(+30.5%) |
| Mar 2014 | - | $104.60 M(+16.3%) |
| Dec 2013 | $89.96 M(-57.6%) | $89.96 M(-11.7%) |
| Sep 2013 | - | $101.91 M(+10.4%) |
| Jun 2013 | - | $92.31 M(-29.8%) |
| Mar 2013 | - | $131.54 M(-38.1%) |
| Dec 2012 | $212.40 M(+48.9%) | $212.40 M(+8.8%) |
| Sep 2012 | - | $195.16 M(+17.9%) |
| Jun 2012 | - | $165.58 M(+4.1%) |
| Mar 2012 | - | $159.10 M(+11.5%) |
| Dec 2011 | $142.67 M(+27.7%) | $142.67 M |
| Dec 2010 | $111.70 M | - |
FAQ
- What is Globus Medical annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Globus Medical?
- What is Globus Medical annual cash & cash equivalents year-on-year change?
- What is Globus Medical quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Globus Medical?
- What is Globus Medical quarterly cash and cash equivalents year-on-year change?
What is Globus Medical annual cash & cash equivalents?
The current annual cash & cash equivalents of GMED is $467.29 M
What is the all time high annual cash & cash equivalents for Globus Medical?
Globus Medical all-time high annual cash & cash equivalents is $467.29 M
What is Globus Medical annual cash & cash equivalents year-on-year change?
Over the past year, GMED annual cash & cash equivalents has changed by +$316.83 M (+210.56%)
What is Globus Medical quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of GMED is $622.77 M
What is the all time high quarterly cash and cash equivalents for Globus Medical?
Globus Medical all-time high quarterly cash and cash equivalents is $622.77 M
What is Globus Medical quarterly cash and cash equivalents year-on-year change?
Over the past year, GMED quarterly cash and cash equivalents has changed by +$343.15 M (+122.72%)